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Abstract 
 
The design, synthesis, modeling and in vitro testing of channel-forming peptides derived from the 
cys-loop superfamily of ligand-gated ion channels are part of an ongoing research focus. Over 300 
different sequences have been prepared based on the M2 transmembrane segment of the spinal cord 
glycine receptor α-subunit. A number of these sequences are water-soluble monomers that readily insert 
into biological membranes where they undergo supramolecular assembly, yielding channels with a range 
of selectivities and conductances. Selection of a sequence for further modifications to yield an optimal 
lead compound came down to a few key biophysical properties: low solution concentrations that yield 
channel activity, greater ensemble conductance, and enhanced ion selectivity. The sequence 
NK4-M2GlyR T19R, S22W (KKKKPARVGLGITTVLTMRTQW) addressed these criteria.  The 
structure of this peptide has been analyzed by solution NMR as a monomer in detergent micelles, 
simulated as five-helix bundles in a membrane environment, modified by cysteine-scanning and studied 
for insertion efficiency in liposomes of selected lipid compositions. Taken together, these results define 
the structural and key biophysical properties of this sequence in a membrane. This model provides an 
initial scaffold from which rational substitutions can be proposed and tested to modulate anion 
selectivity.  
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1. Introduction  
Mutations in genes encoding ion channel proteins result in defective or absent channels, which are 
accompanied by the development of disease pathogeneses. One such channelopathy is cystic fibrosis 
(CF), the hereditary disease caused by mutations in the gene coding for the CF transmembrane 
conductance regulator (CFTR) [1]. Numerous cataloged mutations cause loss of function or poor 
cytosolic trafficking of the CFTR anion channel [1, 2] and lead to epithelial electrolyte transport 
abnormalities [3, 4] in several organ systems [2]. Ion-channel defects have been identified also in 
cation-selective channels, among which potassium channels are prevalent. A few examples include: 
persistent hyperinsulinemic hypoglycemia of infancy and Bartter’s syndrome resulting from a 
loss-of-function of inwardly rectifying potassium channels [5] or neuromyotonia and episodic ataxia 
type 1 caused by dysfunctional voltage-sensitive potassium channels [6].  
Symptomatic current treatment approaches for channelopathies focus on replacing or restoring function 
to defective ion channels or attenuating their negative phenotypic effects by employing 
mutation-specific pharmacotherapies [1], pharmacoagents alone [7, 8] or a variety of genetic approaches. 
None of the available approaches is fully successful. An alternative to existing therapies could be the use 
of synthetic channel-forming peptides (CFPs), which would generate an ion-conducting pore with the 
appropriate CFP selectivity in appropriate tissues. CFPs can be de novo sequences [9, 10] or based on 
segments of native proteins. The use of chemistry to design compounds corresponding to putative 
transmembrane regions of natural proteins yields detectable channel activities of CFPs in planar lipid 
bilayers [11-13] and human erythrocyte membranes [14]. Even though such constructs can be studied in 
greater detail than their parent proteins, CFPs are difficult to deliver from aqueous solution, lack the 
regulatory complexity of native proteins and exhibit reduced ion selectivity. However, since vectorial 
ion transport across epithelial tissues is accomplished with a constellation of contributing components, it 
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is generally believed that some physiological regulation of complimentary proteins can modulate 
processes mediated by synthetic CFPs. 
The glycine receptor (GlyR) was an obvious lead structure for developing an anion selective CFP 
because it is a ligand-gated anion channel [15] and a member of the cys-loop super family of 
ligand-gated channels [16]. GlyR is a heteropentameric oligomer [14, 16] with four α subunits and one β 
subunit [14].  The water-filled pores are formed by the association of the second transmembrane 
segment (M2) contributed by each of the five subunits. An α-subunit homopentameric channel 
recapitulated physiological functions when expressed and evaluated in Xenopus oocytes [17]. This result 
suggested that an assembly of α-M2 sequences could generate a functional anion selective channel. 
Indeed, the native -subunit M2 segment, PARVGLGITTVLTMTTQSSGSRA, forms chloride selective 
channels in lipid bilayers and single cells, and facilitates ion transport across epithelial monolayers [18, 
19]. The first sequence showed net transepithelial ion transport comparable to the parent M2GlyR 
channel pore [18], but poor efficiency with regard to membrane insertion and a tendency to form 
aggregates in aqueous solutions [18, 19].  Subsequently, template-variants of the pore-lining M2 
segment in a single peptide were prepared to evaluate the stoichiometry of the functional pore [12, 18, 
20-23]. Results indicated that monomers assembled into pentameric structures where all of the peptides 
were inserted in the membrane with the same orientation. Preparing such large peptides, however, was 
too labor intensive and too expensive to be practical from a therapeutic standpoint. Studies were thus 
focused on preparing a monomer that would self-assemble into an anion selective pore. 
Peptide sequences were modified by introducing multiple lysyl-residues at the N-termini to improve the 
solubility of the peptide and ensure the uniformity of orientation in the membrane [24]. Lysines at the 
termini of transmembrane sequences position themselves in the aqueous phase near the lipid phosphate 
groups [25] while their side chains direct electrostatic interactions with ions [26], the later could aid in 
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anion selectivity. A tetralysyl tail on these peptides proved optimal, giving enhanced solubility without 
apparently altering channel properties [24]. Subsequently, the sequence was truncated by five residues at 
the C-terminus and the resulting C-terminal serine was replaced by tryptophan to reduce or eliminate 
solution aggregation [27-30]. As a result the peptide showed better efficiency of insertion into epithelial 
cell membranes [27], a decreased propensity for aggregation in aqueous solution [24, 28] and increased 
transepithelial net ion transport at lower peptide concentrations when compared to the wild-type 
M2GlyR sequence [28]. Tryptophan and lysine play important roles in peptide orientation and in 
membrane insertion [25]. Tryptophan in proteins with transmembrane segments is known for its specific 
affinity for sites near the lipid carbonyl region [25]. A tryptophan containing sequence exhibited a 
decrease in the concentration required for net transepithelial ion conductance and an increase in the 
ability to adopt a helical secondary structure [29-31]. Furthermore, tryptophan and arginine reportedly 
play roles as anchors of transmembrane helices [32]. The threonine at position 19 was replaced with 
arginine to introduce a second anchor [30]. The resulting peptide showed increased net transepithelial 
ion conductance compared to the non-substituted wild type peptide. This sequence was also tested for 
antigenic activity in mice at proposed clinical dosages [33], and was negative. A descriptive name, 
NK4-M2GlyR p22-T19R S22W, was given to this peptide: (KKKKPARVGLGITTVLTMRTQW). The 
structural and biophysical characteristics of NK4-M2GlyR p22-T19R S22W, a lead candidate peptide 
with potential as a therapeutic agent, are included in this report. The structure of a monomer was 
analyzed by circular dichroism (CD) and determined by solution nuclear magnetic resonance (NMR) in 
both trifluoroethanol (TFE) and sodium dodecylsulfate micelles (SDS). The outcomes indicated that a 
monomer of NK4-M2GlyR p22-T19R S22W adopts a linear helical structure in hydrophobic 
enviornments. Structural models of the assembled pentameric channel were then constructed by 
incorporating additional experimental data and theoretical considerations. Subsequent 100-200 ns 
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simulations of the channel structures in fully solvated lipid bilayers predicted the most probable 
handedness of helix assembly in the channel and suggested that the peptide was able to form well 
ordered pores in a membrane. A parallel set of experiments was conducted to identify the pore-lining 
residues of assembled NK4-M2GlyR p22-T19R S22W monomers by introducing selected cysteine 
modifications followed by channel blockade with thiol binding mercurial salts. While most sequences 
failed to insert into the synthetic bilayers, several sequences provided positional data on the location of 
pore-lining residues. Importantly, the identities of these pore-lining residues are fully consistent with 
those predicted by atomistic simulations. This suggests that the proposed structure of the pentameric 
channel formed by NK4-M2GlyR p22-T19R S22W is realistic, thus providing a structural basis for 
understanding the channel activity and for devising rational strategies to design new sequences with 
improved functions. Efficiency of peptide insertion into artificial membranes was also evaluated, as the 
ability of synthetic peptides to interact with membranes depends not only on peptide’s sequence [25] but 
also on the lipid composition of targeted membranes [25, 34]. Lipids commonly present in bacterial and 
mammalian cell membranes were employed, as these surfaces will be encountered by CFPs when 
employed therapeutically. As detailed structure/function information on synthetic channels still remain 
largely unknown, the reported results add new information to the field of synthetic pore design. 
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2.  Materials and methods 
2.1. Peptide synthesis and purification  
Peptides were synthesized using solid-phase peptide synthesis (Applied Biosystems Model 431A 
peptide synthesizer; Foster City, CA) employing 9-fluorenylmethoxycarbonyl (Fmoc) chemistries [24, 
35, 36]. CLEAR amide resin, (0.3 mmol/g; Peptides International, Louisville, KY) and N

-Fmoc amino 
acids (Anaspec Inc., San Jose, CA) were used. All peptides were HPLC (System Gold HPLC; Beckman 
Instruments, Inc., Fullerton, CA) purified using a reversed-phase C-18 column (Phenomenex, Torrance, 
CA) and eluted from the column using a linear gradient of 3.0% min
-1
 of 10 - 90% acetonitrile 
containing 0.1% trifluoroacetic acid (TFA) at 1 mL/min [37]. HPLC-purified peptides were 
characterized by matrix-assisted-laser desorption time-of-flight mass spectroscopy (MALDI-TOF/TOF; 
Bruker Ultraflex III, Bruker Daltronics, Billerica MA). After characterization, peptides were lyophilized 
and stored as dry powders until used. All peptide concentrations were determined by measuring the 
absorbance at 278 nm, and using the tryptophan extinction coefficient (ε) of 5579 M-1cm-1 at 278 nm. 
2.2. CD  
CD (spectropolarimeter models J-720 or J-815, Jasco, Tokyo, Japan) was employed to determine the 
secondary structures of peptides dissolved in water, TFE and SDS using conditions described previously  
[29]. Peptide concentrations ranging from 20 µM to 3 mM were tested depending on the experiment. 
2.3. Solution NMR spectroscopy  
Lyophilized peptide was dissolved in a (1:1) mixture of 1,1,1,3,3,3-Hexafluoro-2-propanol/ 
2,2,2-Trifluoroethanol at 3 mM. This solution was added to SDS dissolved in deionized/distilled (DD) 
H2O at a ratio of peptide to SDS of 1:150. The mixture was vortexed and an excess amount of deionized 
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distilled (DD) H2O was added to equal 16 times the volume of TFE. The later step ensured that the 
peptide inserted into the micelles. The sample was lyophilized overnight and then the NMR sample 
prepared by dissolving the dry powder in 90% H2O and 10% D2O. Use of different solvents for the 
NMR sample preparation showed that SDS micelles are optimal for stabilizing the peptide's structure 
thereby yielding better NOE constraints. 
Spectra of the NK4-M2GlyR p22-T19R, S22W peptide were recorded at 40°C (Bruker Avance-800 
NMR spectrometer, Bruker Instruments, Billerica, MA) equipped with a triple resonance probe. The 
duration of the 90º pulse was ~9 μs for 1H. Two-dimensional NOESY and TOCSY data were acquired 
in phase-sensitive (States-TPPI) mode into 2048 t2 and 256 t1 points with spectral width of 10 ppm in 
each dimension, and 72-80 transients per increment. A spinlock time of 100 ms was used for TOCSY 
and mixing times of 100 and 200 ms for NOESY were used. For suppression of the solvent peak, the 
WATERGATE pulse scheme was applied in the TOCSY experiment and water flipback was used for 
the NOESY experiment. Data from both sets of experiments were processed using NMR Pipe [38] and 
analyzed using Sparky software [39]. NMR structure calculations were prepared as described previously 
[29].  
2.4. Molecular modeling and simulation protocols 
Three models of the putative pentameric pore were constructed with three different handedness 
orientations of helix packing: left-handed, straight and right-handed, using a strategy similar to previous 
work [31]. The pentameric structures were solvated in pre-equilibrated POPC bilayers using the 
CHARMM-GUI automated Membrane Builder [40, 41]. The final systems consisted of ~100 lipids, 
~4800 water molecules, ~10 K
+
 and ~40 Cl
-
, besides the proteins. The box size was ~65 × 65 × 72 Å. A 
protocol similar to one used in previous work [31] was applied to equilibrate the system at 303 K using 
CHARMM [42, 43], during which various restraints were applied to selected heavy atoms with 
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gradually decreasing restraint strength. SHAKE was used to fix the length of hydrogen-attaching bonds 
[44], particle mesh Ewald (PME) [45] was used for long-range electrostatic interactions, and van der 
Waals interactions were smoothly switched off from 10 to 12 Å. The equilibrated structures were then 
used to initiate production simulations using NAMD [46]. Another 100 ps equilibration simulation with 
weak harmonic positional restraints on protein backbone atoms (k = 0.1 kcal/mol/Å
2
) was used to 
suppress potential strains during subtle differences between CHARMM and NAMD. Setups equivalent 
or identical to those used in CHARMM equilibration simulations were used in NAMD runs. The length 
of production simulation was 100 ns for left-handed and straight pore assemblies, and extended to 200 
ns for the right-handed model to probe the preferred handedness of the pore assembly further. These 
simulations are much longer than those published previously for NK4-M2GlyR p22 and NK4-M2GlyR 
p22-S22W pores [31]. The purpose of longer simulations is to better exploit the force field to resolve the 
handedness of pore assembly, a key feature that has not been determined experimentally. The 
coordinates were saved every 1 ps for post-analysis. All analyses were performed using CHARMM. 
VMD [47] was used for visualization and preparation of molecular images for presentation. The pore 
profiles and estimated ion conductances were calculated using the program HOLE with default options 
[34]. 
2.5.  Identification of pore-lining residues 
2.5.1 Cysteine scanning study  
Seventeen cysteine substituted variants of NK4-M2GlyR p22-T19R, S22W were synthesized. The 
following replacements were synthesized as described above: K3C, K4C, P5C, A6C, V8C G9C, L10C, 
G11C, I12C, T13C, T14C, V15C, L16C, T17C M18C, T20C and Q21C. Three peptide concentrations 
(60, 100, and 200 μM) were employed to assess effects on short-circuit current (ISC), a sensitive 
indicator of net active ion transport across epithelial monolayers, as described below. 
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2.5.2 Trans epithelial ion transport measurements   
Madin-Darby canine kidney (MDCK) epithelial cells were a generous gift of Dr. Lawrence Sullivan 
(KUMC, Kansas City, KS). The cells were cultured as described previously [19]. 
1-ethyl-2-benzimidazolinone (1-EBIO; Acros, Morris Plains, NJ) was prepared as a 1 M stock solution 
in dimethyl sulfoxide (DMSO).  
Transepithelial ion transport was evaluated employing modified Ussing chambers (Model DCV9, 
Navicyte, San Diego, CA). MDCK cell monolayers were mounted vertically in chambers. Apical and 
basolateral aspects of the monolayers were bathed in a modified Ringer solution (in mM; 120 NaCl, 25 
NaHCO3, 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, and 1.2 CaCl2), which was prepared fresh daily and all 
components were purchased from Sigma-Aldrich (St. Louis, MO). The bathing solution was kept at 37 
º
C and continuously bubbled with 5% CO2/ 95% O2 to maintain pH, provide aeration and mix fluid in 
chambers. Experiments were conducted on monolayers with a resistance of at least 600 Ohms cm
2
. The 
transepithelial membrane potential (VTE) was clamped to 0 mV and the ISC measured continuously with a 
voltage clamp apparatus (Model 558C, University of Iowa, Department of Bioengineering, Iowa City, 
IA). Data acquisition was performed at 1 Hz with an Intel-based computer running AcqKnowledge 
software (version 3.7.3, BIOPAC Systems, Santa Barbara, CA) with an MP100A-CE interface. The data 
points represent the mean ISC stimulated by the peptides at the indicated concentrations. Bars indicate the 
standard error of the mean. The differences between the control and treatment data were analyzed using 
ANOVA and Student’s t-test. The probability of making a type I error less than 0.05 was considered 
statistically significant. The lines presented in some figures represent the best fit of a modified Hill 
equation to the data, ISC = IMAX  (x
n
 / (K 
n
 1/2 + x
n
); where K1/2 is the concentration of peptide that 
provides a half maximal ISC and n represents the Hill coefficient.  
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2.6. Interaction of NK4-M2GlyR p22-T19R, S22W with large unilamellar vesicles  
All phospholipids were purchased from Avanti Polar-Lipids, Inc., (Alabaster AL). Stock solutions of 
POPC: (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), POPG:(1-Palmitoyl-2-oleoyl-sn-glycero-3- 
phospho-rac-(1-glycerol)), POPS: (1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine), POPE: 
(1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), DLPC: (1,2-Dilauryl-sn-glycero-3 
-phosphocholine) and DLPG: (1,2-Dilauryl-sn-glycero-3-phospho-rac-(1-glycerol)) stored in chloroform 
were used and mixed by volume to obtain the appropriate molar ratios of negatively charged 
phospholipids. The chloroform was evaporated under a stream of nitrogen gas. Lipid mixtures were 
resuspended in deionized water at room temperature to yield a total lipid concentration of 10 mM. 
Suspensions were incubated at 40 
°
C for an hour with frequent vigorous agitation and then passed 
through polycarbonate membrane (100 nm pore size; Avanti Mini extrude, Avanti Polar-Lipids, Inc.) to 
prepare large unilamellar vesicles (LUVs). One mL of LUV suspension was placed into a cleaned vial 
and 1 mL of peptide (10 µM) was added, giving final concentrations of lipid and peptide of 1 mM and 5 
µM, respectively.  
2.7. Fluorescence Spectroscopy  
Fluorescence spectroscopy was employed for blue shift analyses in the emission spectra for 
peptides inserted into micelles with different lipid combinations.  Fluorescence spectra were 
recorded (Hitachi F-4010 or Cary Eclipse fluorescence spectrophotometer with an excitation slit width 
of 3-5 nm and emission slit width of 5 nm. The excitation wavelength was set at 278-280 nm and the 
emission spectra recorded from 300 to 500 nm. All measurements were made in a 10 x 10 mm cuvette at 
25 
º
C. For samples containing vesicles, the background was subtracted from the peptide-containing 
samples. A final peptide concentration of 5.0 µM in deionized water or in 1 mM freshly prepared large 
unilamellar vesicles (LUVs) of either POPC:POPG (7:3) or DLPC:DLPG (7:3) was used. This protocol 
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was adapted from that described previously [49]. 
Peptide and liposome solutions were incubated one hour prior to recording the spectra. Values recorded 
from a sample containing only liposomes was subtracted from the samples containing the vesicles and 
peptide. All the measurements were performed in triplicate. The lipid:peptide molar ratio was kept at 
200:1 throughout all experiments. 
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3. Results and Discussion 
The peptide NK4-M2GlyR p22-T19R, S22W represents the best candidate for additional modifications 
and/or potential therapeutic use. Substitutions made to the parent NK4-M2GlyR p27 sequence (Table 1) 
yielded a peptide with many desirable properties that relate to solubility, aggregation, immune and 
inflammatory responses and ion permeation. In producing this well-behaved sequence, anion selectivity 
was negatively impacted. The parent NK4-M2GlyR p27 sequence had permeation selectivities greater 
than 25:1 for monovalent anions over monovalent cations [24]. This value in NK4-M2GlyR p22-T19R, 
S22W is now 1.4:1 [30]. Before planning additional substitutions to remedy this shortcoming,  the 
structure of this peptide had to be determined to identify pore-lining residues. During these studies it 
was observed that lysine containing sequences produced robust current generating responses in epithelial 
monolayers and oocytes but not in synthetic bilayers. Therefore the insertion efficiency into synthetic 
membranes with different binary lipid compositions was analyzed to begin to understand this 
phenomenon.  
3.1. Overall secondary structure characteristics 
Employing CD, the mean molar ellipticity spectrum for NK4-M2GlyR p22-T19R, S22W (50 μM) was 
generated and compared to those recorded for three earlier designs: NK4-M2GlyR p22, NK4-M2GlyR 
p27-WT and NK4-M2GlyR p22-S22W (Table 1). The spectrum of NK4-M2GlyR p22-T19R, S22W 
indicated helical content with characteristic α-helix double minima at 208 and 222 nm and a maximum 
at ~192 nm. Similar characteristics were obtained for other related peptides, as shown with overlaid 
spectra (Fig. 1). Results are in agreement with secondary helical structures determined in previous 
studies with these earlier sequences [29, 30]. The spectra indicate that the replacement of the threonine 
at position 19 with the cationic arginine residue does not affect the propensity to adopt a helical 
conformation in a hydrophobic environment. 
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Prior to collecting any NMR spectra, the effect of peptide concentration on secondary structure and 
aggregation in SDS were assessed as a function of time. The peptide was analyzed at two 
concentrations, 50 μM and 3.0 mM, which was used also for the NMR experiments. Spectra were 
obtained in a 200-fold molar ratio of detergent monomer to peptide for the SDS micelles (10 mM and 
600 mM, respectively) at various temperatures. Under these conditions there should be, on average, just 
one peptide per micelle. When corrected for peptide concentration the results obtained at the two 
concentrations were indistinguishable and indicated that the peptide did not aggregate at the 
concentration and temperatures used for NMR (data not shown). Samples that were stored at room 
temperature showed no discernable change in their CD spectra when re-examined over a two-week period.  
3.2. Solution Nuclear magnetic resonance (NMR) 
The different NMR spectra of NK4-M2GlyR p22-T19R, S22W were recorded in deuterated SDS. Under 
the conditions employed, the structure generated is of the monomer encapsulated within a C12 acyl chain 
detergent micelle. All spectra were indistinguishable from those used to generate the solution NMR 
structure for NK4-M2GlyR p22-S22W [31]. The new results show that residues 10-20 of NK4-M2GlyR 
p22-T19R, S22W have resonances expected for helical conformation, while the N-terminus is largely 
disordered. Overlaying the NOESY spectrum for NK4-M2GlyR p22-T19R, S22W with that of 
NK4-M2GlyR p22-S22W shows significant similarities and several important differences (Fig. 2, Table 
2). The two-dimensional 
1
H-
1
H
 
NOESY analysis provided 150 distance constraints, 52 of which were 
inter-residue constraints (sequential, medium and long range). A number of long-range NOE 
connectivities typical for α-helical conformation were observed. In 2D 1H-1H NOESY spectra, dαβ (i, 
i+3) connectivities were identified for G11-T14, I12-V15, V15-M18 and L16-R19. Six dihedral angle 
constraints were calculated from 
3
J coupling constants. The target function for the structure was 0.30 ± 
0.12 Ǻ. NOE constraint violations were limited and the sum of the violations was 1.68 ± 0.50 Ǻ. 1 
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dihedral angle violation of 0.25º was observed. Ramachandran values showed that the backbone 
torsional angles were all within allowed regions.  
Table 2 shows data obtained for this peptide. Structural statistics include the RMSD value for the 
structures within the cluster from the mean structure with lower values obtained for NK4-M2GlyR 
p22-T19R, S22W compared to values previously published for NK4-M2GlyR p22-S22W [29]. 
Representative conformation models for solution structures of both peptides are shown in Fig. 3. The 
peptides adopt slightly different conformations. NK4-M2GlyR p22-S22W appears to have a more curved 
structure while NK4-M2GlyR p22-T19R, S22W adopts a more linear conformation. These sequences 
were subsequently analyzed as five-helix assemblies using MD simulations. 
3.3. Structural characterization of the channel assembly 
3.3.1. Stability of the channel structures in POPC bilayers  
Three models of the putative pentameric pore of NK4-M2GlyR p22-T19R, S22W (Fig. 4) were 
constructed with different handedness of helix packing: left-handed, straight and right-handed, 
respectively. Similar to previous work with NK4-M2GlyR p22-S22W (31), the tilt angle of the initial 
left-handed and right-handed models is 15°. The initial pore-lining face was based on a consideration of 
the peptide's amphipathicity. 
All three constructed structural models (Fig. S2), are stable throughout the production simulations. The 
ranges of RMSD values of the pore assembly as well as individual monomers from the initial models are 
similar to those for NK4-M2GlyR p22 and NK4-M2GlyR p22-S22W pores [31]. The moderate RMSD 
values are due mainly to the unstructured N-terminal lysines and flexibility in the channel assembly 
itself. Figs. 5 and S3 depict the evolution of the positions of the centers of the mass and two termini 
along membrane normal during the production simulations. Interestingly, NK4-M2GlyR p22-T19R, 
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S22W channels appear to show substantial fluctuation along the membrane normal similar to 
NK4-M2GlyR p22 channels [31]. This suggests that T19R mutation could attenuate the membrane 
anchoring effects of NK4-M2GlyR p22-S22W. Importantly, the secondary structures and overall 
features of the pore assemblies (such as helix-helix packing interfaces and pore-lining residues analyzed 
below) are well conserved. For example, as shown in Fig. S4, the overall helicity stabilizes at ~70%, 
similar to the values observed for NK4-M2GlyR p22 and NK4-M2GlyR p22-S22W pores [31]. General 
conservation of the secondary and tertiary fold across all three sequences (NK4-M2GlyR p22, 
NK4-M2GlyR p22-S22W, and NK4-M2GlyR p22-T19R, S22W) is not surprising, as all these sequences 
have been shown to be capable to insert and form active channels, albeit with different levels of ion 
conductance. 
 
3.3.2. Handedness of helical assembly  
One of the unresolved structural features of the putative pores formed by M2GlyR-derived peptides is 
the most probable handedness of the helical assembly. Even though all available crystal structures of 
cys-loop ligand-gated ion channels contain left-handed packing of pore-forming transmembrane helices 
[52-54].  Previous simulations of limited length (20 ns) of NK4-M2GlyR p22 and NK4-M2GlyR 
p22-S22W channels were not able to identify any apparent difference between right- and left-handed 
assemblies [31]. One of the key objectives of the current simulations was thus to resolve this issue. 
Three models of the putative pentameric pore of NK4-M2GlyR p22-T19R, S22W (Fig. 4) were 
constructed with different handedness of helix packing: left-handed, straight and right-handed, 
respectively. Similar to our previous work on NK4-M2GlyR p22-S22W [31], the tilt angle of the initial 
left-handed and right-handed models is 15°. The initial pore-lining face suggested was based on a 
consideration of the peptide's amphipathicity. 
 17 
As shown in Fig. 6, the straight assembly drifted gradually towards left-handedness over the course of 
100 ns production simulation, and adopted stable packing with a twist angle similar to the equilibrium 
value reached by the simulation of the left-handed assembly. The right-handed channel also appeared to 
drift toward left-handedness and became largely straight by the end of the first 100 ns production 
simulation. Therefore, simulation of the right-handed assembly was extended for another 100 ns, during 
which the channel indeed managed to switch the handedness around 160 ns. The final state at the end of 
the 200 ns production simulation is a left-handed assembly on average. However, the average twist 
angle (~8º) is significantly lower than the equilibrium values reached by simulations of the straight and 
left-handed assemblies (~20º), as shown in Fig. 7 and Supplement Materials (Fig. S1). The lower 
average twist angle is due to the heterogeneity in the assembly: only four of the five individual 
helix-helix packing interfaces switched to left-handed packing at the end of 200 ns simulation. It can be 
expected that the channel will eventually become fully left-handed with longer simulations. Therefore, 
longer production simulations reported here seem to resolve the handedness of the putative channels 
formed by M2GlyR-derived peptides and predict that these synthetic channels most likely have the same 
left-handed pore assembly as observed in the crystal structures of the full length channels. 
 
3.3.3. Helix packing, membrane-exposed and pore-lining residues  
Details of helix packing and residue distribution of the pore were analyzed. The initial focus was on the 
left-handed assembly (Section 3.3.1.) that has been predicted to be the native state. Results summarized 
in Fig. 8a demonstrate that the pore is mainly lined with A6, R7, L10, T13, T14, T17, T20 and Q21. 
Note the N- and C-terminal residues, K1-4 and W22, should not be considered as pore-lining, even 
though they are indicated to have high pore-lining probabilities based on their contacts with (bulk) water 
molecules. The predicted pore-lining interface is largely consistent with the one derived from 
consideration of amphipathicity. However, the predicted pore-lining interface is broader due to 
 18 
substantial fluctuations of the pore. Participation of residues in helix-helix packing is characterized by 
calculating the average burial areas of side-chains, shown in Fig. 9b. Clearly, most residues with the 
structured region contribute to helix-helix interactions, except G9, G11, I12, V15 and R19. These 
residues either lack side chains (G9 and G11) or are fully membrane exposed. (I12, V15, L16 and R19). 
L10 and Q21 appear to be particularly important for stabilization of the pore assembly with largest 
buried surface areas (Fig. 8b).  
3.3.4 Pore profiles 
Average pore profiles calculated from the production simulations are shown in Fig. 9. The profiles 
derived from simulations of left-handed and straight assemblies are similar, consistent with the 
observation that the straight assembly evolved completely to a left-handed one (see above). The pore 
profile derived from the simulation of the right-handed channel is slightly different from the other two, 
apparently due to a lack of convergence within 100 ns. Nonetheless, all three assemblies have similar 
radii at the narrowest region (near Thr17). Curiously, the p22-T19R, S22W pore appears to be slightly 
narrower than both p22 and p22-S22W pores [31]. This does not appear to be consistent with increased 
conductance measured using MDCK monolayers. It is not clear that this is an artifact of much longer 
simulations used in the current work compared to the previous work. Further free energy calculations 
using similarly refined structural models, together with new single channel measurements, will help to 
further clarify whether the atomistic modeling is able to recapitulate the expected difference in channel 
activity.  
3.4. Cysteine scanning 
Seventeen individual peptides with single cysteine substitutions at indicated positions in NK4-M2GlyR 
p22-T19R, S22W (Table 7) were tested for their ability to induce ion secretion across the MDCK 
monolayers (Fig. 10) and identify any possible non-permissible substitution sites. The N-terminal 
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lysines at positions 1 and 2, the arginines at positions 7 and 19 and tryptophan at the C-terminus were 
not substituted due to their involvement in insertion orientation, ion selectivity or membrane anchoring 
functions. The shaded grey bars in the figure represent the ISC ± S.E.M. range for the parent 
NK4-M2GlyR p22-T19R, S22W peptide at 60, 100, and 200 μM concentrations (bottom to top). The 
same three concentrations were used for each of the test sequences and are represented, for clarity, as 
slightly offset bars (laterally) that show the measured ISC ± S.E.M. values. They are plotted above the 
corresponding amino acid replaced by the cysteine. Net transepithelial ion transport rates showed that 
the replacements at the more terminal sites, K3, K4, P5, A6 or T17, M18, T20 and Q21 yielded transport 
rates higher at each concentration than that observed for the parent NK4-M2GlyR p22-T19R, S22W. 
Replacements in the central membrane embedded region generally led to lower flux values relative to 
NK4-M2GlyR p22-T19R, S22W except for the pore contributing Leu10, which yielded results nearly 
identical to the parent sequence. The lowest activities were observed for the cysteine substitutions at 
positions G9, G11, I12, V15 and L16.  As discussed earlier these residues are most likely facing lipid 
and posses either no side chain or extended hydrophobic side chains. Introduction of a short hydrophilic 
side chain in these positions could affect membrane insertion or helix-helix packing.  
The results are partially supported by the computer modeling assignments of the pore lining residues 
consisting of T13 and T17.  Placing cysteine at position 17 resulted in an increase in ISC while the 
cysteine at position 13 showed a decrease in ISC compared to NK4-M2GlyR p22-T19R, S22W. This is an 
indication that T13 might not be a part of pore-lining surface, but could play a role in structural 
properties of assembled pore. This is in agreement with calculations based on refined NMR monomer 
structure showing the potential involvement of T13 in structural modifications of the pore. The 
narrowing of the pore observed in NK4-M2GlyR p22-S22W, which was absent in NK4-M2GlyR 
p22-T19R, S22W indicates that the position of the ring of OH groups contributed by Thr13 in 
 20 
NK4-M2GlyR p22-T19R, S22W have likely become repositioned thereby widening the pore and 
explaining the increased conductance observed. 
3.5. Blockade experiments in artificial bilayers 
The cysteine substituted peptide variants of NK4-M2GlyR p22-T19R, S22W were tested using synthetic 
bilayers in hopes of identifying the pore lining residues through channel blockade upon the addition of a 
mercurial salt. These experiments were, for the most part, unsuccessful. High resistance bilayers (70:30 
POPC:POPS from decane) were formed at 100mV, bathed in a symmetrical 0.1 M KCl, and allowed to 
stabilize before adding peptide (1-10 nM). Numerous attempts had to be made before obtaining just a 
few suitable channels for the following peptides (1) NK4-M2GlyR p22-T14C, T19R, S22W, (2) 
NK4-M2GlyR p22-V15C, T19R, S22W and (3) NK4-M2GlyR p22-V15C, T19R, S22W. No other 
sequences yielded recordable channels. For the three peptides where channel activity commenced, 
increasing concentrations of HgCl2 were added and the decrease in channel activity recorded. Based on 
the low concentration of HgCl2 required to inhibit channel activity for the T17C substitution, position 17 
appears to be present in the pore of the channel. Based on the intermediate concentration of HgCl2 
required to inhibit channel activity for the T14C substitution, this residue may be near or part of a 
helix-helix interface. Based on the high concentration of HgCl2 that fails to inhibit channel activity for 
the V157C substitution, this residue appears to face the lipids in the membrane. The results obtained for 
the three residues that produced pores are consistent with the modeling studies presented above. 
3.6. Interaction of NK4-M2GlyR p22-T19R, S22W with LUVs of a series of POPC:POPS, 
POPC:POPE and POPC:POPG composition 
Most of the tested sequences failed to show any channel activity in the bilayer assay. The fact that these 
sequences generate measurable ion conductances in epithelial monolayers suggested that the lack of 
complexity in composition of the synthetic membrane affect the insertion and assembly of the peptides. 
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We therefore tested the ability and efficiency of insertion of NK4-M2GlyR p22-T19R, S22W into 
liposomes composed of POPC: POPS, POPC:POPE and POPC:POPG (Tables 3-5).  These 
experiments show maximal blue shifts of 21 and 10 nm measured when NK4-M2GlyR p22-T19R, S22W 
was mixed with POPC:POPS and POPG (7:3) liposomes and a shift of 11 nm when mixed with 
POPC:POPE (6:4) liposomes, compared to dissolved peptide alone or liposomes alone with the absence 
of shifts. When the peptide was mixed with the vesicles composed of 100 % POPC, which is a 
zwitterionic phospholipid, the peptide/liposome spectra did not give evidence of partition into the LUV 
(data not shown). One possible explanation is that the peptide may be lying on the surface of the 
liposome due to electrostatic interaction of the glycerol head groups on the phospholipids and oligo 
lysine N-terminus on the peptide.  
The orientation of membrane proteins can be guided by a contact between negatively charged 
phospholipids and positively charged amino acid residues [55]. This is in agreement with results that 
show better insertion of peptide when it is exposed to phospholipid mixtures containing anionic 
phospholipids (POPC:POPS; 7:3), possibly due to more favorable attractive electrostatic interactions. 
Further when POPC:POPS and POPC:POPE either at 10% or 20% of anionic phospholipid were tested 
results show that these ratios are insufficient to assist the peptide’s insertion. Similarly 50% POPS or 
POPE also did not show an increase of blue shift indicating unfavorable conditions for peptide insertion. 
 
Conclusions 
Redesign of synthetic channel forming peptides based on the transmembrane segments of natural ion 
channel proteins is a challenging task. When assembling into a pore, NK4-M2GlyR p22-T19R, S22W 
peptides form a synthetic construct resembling only the ion conductive part of its parent protein, 
therefore lacking a complex set of regulated control of assembly and function owned by its natural 
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parent. However, lacking regulatory characteristics can be seen as limitations or a unique advantage. 
Various modifications of original putative protein sequences can lead to specific structure/function 
modified synthetic channels, carefully designed to meet the needs for targeted therapeutic use. The best 
candidate synthetic amphiphilic peptide, NK4-M2GlyR p22-T19R, S22W presented in this study serves as 
a good scaffold for further detailed structure-function modifications aimed to tune its selectivity. 
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FIGURE LEGENDS 
 
Figure 1. Circular dichroism spectra of NK4-M2GlyR derived peptides in 10 mM SDS micelles. 
Spectra represented include peptides: NK4-M2GlyR p27 WT (), NK4-M2GlyR p22 (), NK4-M2GlyR 
p22-S22W (), and NK4-M2GlyR p22-T19R, S22W () with peptide concentrations of 50 µM. Spectra 
were recorded at ambient temperature (22 ºC) and represent averages of eight scans after subtraction of 
the reference spectra of the media.  
 
Figure 2. Overlay of the NOESY spectra of NK4-M2GlyR p22-S22W (yellow) and NK4-M2GlyR 
p22- T19R, S22W (blue).   
 
Figure 3. Calculated structure models of p22-S22W (left) and p22-T19R S22W (right) in SDS 
micelles. A representative conformation was modeled for the solution structures. The backbones are 
shown as a tube with the heavy atoms of the side chains visible in a wire frame. 
 
Figure 4. Initial 3D structural models of the pentameric channels. Side chains of key pore-lining 
residues (T13 and T17), the N-terminal lysines (K1-4), and membrane anchoring arginines and 
tryptophans (R19 and W22) are highlighted. 
 
Figure 5. The centers of mass and N-/C-terminal positions of whole protein and individual monomers of 
the left-handed channels along the membrane normal with respect to the lipid center of mass as 
functions of time. The N- and C-termini are represented by C atoms of K1 and W22, respectively. The 
monomer center of mass was computed using all heavy atoms. The black traces are for whole protein, 
and chromatic traces for individual monomers. 
 
Figure 6. The initial and final snapshots of the simulations of left-handed, straight and right-handed 
assemblies of p22-T19R/S22W. 
 
Figure 7. Evolution of the handiness of helix packing as function of time for left-handed (red), straight 
(green) and right-handed assemblies (blue). The handiness is described by a virtual dihedral angle 
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defined by two pairs of Cα atoms on two adjacent helices, Cα, Leu10 – Cα, Trp22 – C’α, Trp22 – C’α, Leu10. The 
values shown are the averages of five helix-helix twist angles in the pentameric assembly. 
 
Figure 8. a. Probabilities of a residue being either a pore-lining one or a membrane-exposed one. b. 
Average surface area of burial due to peptide-peptide interactions. The results are calculated from the 
last 80 ns of 100 ns production simulation of the left-handed channel. 
 
Figure 9. Pore profiles with standard error bars along the channel principal axis. The averaged profiles 
were computed from snapshots taken very 1.0 ns from 20 to 100 ns production simulations. The 
snapshot pore profiles were calculated using the program HOLE [34]. The C-terminus is on the left and 
N-terminus on the right. 
 
 
Figure 10. Activities of cysteine substituted peptides applied to MDCK epithelial monolayers. The 
anion transport results for seventeen cysteine substituted peptides are shown. Short-circuit current (ISC) 
data are shown at three peptide concentrations. Each vertical bar above a substituted residue represents 
the mean ISC ± s.e.m. and the relative thickness of the bar indicates the concentration (highest 
concentration has thickest line). The shaded horizontal regions indicate the mean ISC ± s.e.m. for the 
parent sequence NK4-M2GlyR p22-T19R, S22W at 60, 100, and 200 μM concentrations. The offset 
vertical bars indicate ISC ± SEM values obtained for the same concentrations of the 
cysteine-substitutions for the amino acids shown at the bottom on the Figure.  
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Supplemental Materials 
 
Figure S1. Evolution of backbone RMSD with respect to the initial during production simulations. The 
black traces correspond to the whole channel RMSD, and the color traces plot those for individual 
helices. 
 
Figure S2. The absolute and relative position along membrane normal (z axis) of some groups as 
functions of time for left-handed, straight and right-handed channel. The upper and lower green curves 
are the center of mass of upper and lower head groups of POPC, and the center green one is that of tail 
groups of POPC. The blue curve is for the center of mass of backbone heavy atoms, the red and purple 
ones for the N- and C-terminal that are represented by C atoms of K1 and S22 respectively. The 
positions of groups for peptide are relative to the center of mass of tail groups of POPC. 
 
Figure S3. Averaged helicities of the whole channel as a function of time. 
 
Figure S4. Evolution of the handiness of helix packing as function of time for left-handed (red) and 
right-handed assemblies (blue). The blue and red traces plot the averages of five helix-helix twist angles 
in the pentameric assembly. The additional traces plot all the five helix-helix twist angles in the 
simulation of the right-handed assembly. 
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Table 1. Sequences of NK4-M2GlyR derived peptides 
Protein ID [ref] Sequence Mol. Wt. 
(Da) 
NK4-M2GlyR p27 WT [19] KKKKPARVGLGITTVLTMTTQSSGSRA 2817.4 
NK4-M2GlyR p22  [28] KKKKPARVGLGITTVLTMTTQS 2358.9 
NK4-M2GlyR p22-S22W [29] KKKKPARVGLGITTVLTMTTQW 2458.0 
NK4-M2GlyR p22-T19R, S22W [30] KKKKPARVGLGITTVLTMRTQW 2512.1 
 
 
 
Table 2. Structure statistics of NK4-M2GlyR p22-T19R, S22W in SDS micelles. 
      NK4-M2GlyR  
p22-T19R, S22W 
Target Function (Ǻ)  0.30 ± 0.12  
Experimental NMR Constraints    
 NOE Distance Constraints    
  Intraresidue  98  
  Sequential  30  
  Medium Range  15  
  Long Range  7  
 Angle Constraints  6  
NMR Constraint Violations    
 NOE constraint violations (Ǻ)    
  Sum  1.68 ± 0.50  
  Maximum  0.44 ± 0.24  
 Angle constraint violations    
  Sum  0.00  
  Maximum  0.00  
Energy (kcal/mol
-1
)    
 Etotal  -15.24 ± 5.34  
RMSD from the mean structure (Ǻ)    
  Residues 9-20 backbone atoms  0.25 ± 0.10  
Ramachandran statistics    
 Residues in allowed regions  > 99%  
 Residues in generously allowed regions  < 0%  
 Residues in disallowed regions  < 0%  
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Table 3: Sequences of Cysteine scanning substituted peptides. 
 
1. NK4-M2GlyR p22 T19R S22W KKKKPARVGLGITTVLTMRTQW 
2. NK-K3C- M2GlyR p22 T19R S22W KKCKPARVGLGITTVLTMRTQW 
3. NK-K4C- M2GlyR p22 T19R S22W KKKCPARVGLGITTVLTMRTQW 
4. NK4-M2GlyR p22 P5C T19R S22W  KKKKCARVGLGITTVLTMRTQW 
5. NK4-M2GlyR p22 A6C T19R S22W  KKKKPCRVGLGITTVLTMRTQW 
6. NK4-M2GlyR p22 V8C T19R S22W  KKKKPARCGLGITTVLTMRTQW 
7. NK4-M2GlyR p22 G9C T19R S22W  KKKKPARVCLGITTVLTMRTQW 
8. NK4-M2GlyR p22 L10C T19R S22W  KKKKPARVGCGITTVLTMRTQW 
9. NK4-M2GlyR p22 G11C T19R S22W  KKKKPARVGLCITTVLTMRTQW 
10. NK4-M2GlyR p22 112C T19R S22W  KKKKPARVGLGCTTVLTMRTQW 
11. NK4-M2GlyR p22 T13C T19R S22W  KKKKPARVGLGICTVLTMRTQW 
12. NK4-M2GlyR p22 T14C T19R S22W  KKKKPARVGLGITCVLTMRTQW  
13. NK4-M2GlyR p22 V15C T19R S22W    KKKKPARVGLGITTCLTMRTQW 
14. NK4-M2GlyR p22 L16C T19R S22W    KKKKPARVGLGITTVCTMRTQW 
15. NK4-M2GlyR p22 T17C T19R S22W   KKKKPARVGLGITTVLCMRTQW 
16. NK4-M2GlyR p22 M18C T19R S22W    KKKKPARVGLGITTVLTCRTQW 
17. NK4-M2GlyR p22 T19R T20C S22W   KKKKPARVGLGITTVLTMRCQW 
18. NK4-M2GlyR p22 T19R Q21C S22W KKKKPARVGLGITTVLTMRTCW 
 
 
Table 4: Large Unilamellar Vesicles (LUVs) made by extrusion with POPC:POPS at different ratios 
(Error ± 1 nm). L/P ratio is 200/1. 
 
POPC 
(mol%) 
POPS (mol%) λmax (nm)  
0 0 356 
100 0 356 
90 10 342 
80 20 339 
70 30 335 
60 40 338 
50 50 339 
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Table 5: Large Unilamellar Vesicles made by extrusion of POPC:POPG at different ratios  
(Error ± 1nm). L/P ratio was 200/1. 
 
POPC 
(mol%) 
POPG 
(mol%) 
λmax (nm) 
0 0 352 
100 0 353 
90 10 351 
80 20 345 
70 30 342 
60 40 344 
50 50 345 
 
Table 6: Large Unilamellar Vesicles (LUVs) made by extrusion with POPC:POPE at different ratios 
(Error ± 1 nm). L/P ratio is 200/1. 
 
POPC 
(mol%) 
POPE (mol%) λmax (nm) 
0 0 355 
100 0 355 
90 10 348 
80 20 349 
70 30 346 
60 40 345 
50 50 348 
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Figure 1. 
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 Figure 2. 
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Figure 3  
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Figure 4. 
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Figure 5  
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Figure 6. 
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Figure 7. 
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Fig 8 
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Figure 9. 
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Figure 10. 
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Supplement materials 
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Figure S2. 
 
 
 
  
 45 
Figure S3. 
 
 
 
Figure S4. 
 
